Fundraising Fox
Orcosa
Ewing, US · Founded 2020 · Delaware corporation
Find your way into Orcosa
Sign up to see every warm intro you have to Orcosa
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Orcosa team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Orcosa is a clinical-stage life-sciences company developing the Rapid Infusion Technology (RITe) platform, orally disintegrating tablets designed to improve drug absorption through the cheek tissue without water. The company controls formulation, development, and manufacturing in-house and is advancing a proprietary cannabinoid composition for the management of pain and inflammation.
Founders & leadership
Orcosa was founded in 2020 by Vincent T. Mileto.
VT
Vincent T. MiletoCo-Founder & Chief Operating OfficerVincent T. Mileto is Co-Founder and Chief Operating Officer of Orcosa, a clinical-stage life-sciences company developing oral disintegrating tablet technology for drug delivery. He holds a Certified Pharmaceutical GMP Professional certification with the American Society for Quality and has experience in pharmaceutical operations and business development.
B`
Bryan ` RidallExecutive
MR
Mark RidallNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$56.5M disclosed across 3 rounds · 2021–2024
▶$7.3MraisedJan 2025 · 17 investors · BiotechnologyRule 506(b)
▶$7.3MraisedJan 2025 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert M. PollaroDirector, Executive Officer
- Bryan RidallDirector, Executive Officer
- Vincent MiletoDirector, Executive Officer
- Offering amount
- $15.5M
- Amount sold
- $7.3M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$11.3MraisedJan 2025 · 36 investors · BiotechnologyRule 506(b)
▶$11.3MraisedJan 2025 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert M. PollaroDirector, Executive Officer
- Vincent MiletoDirector, Executive Officer
- Bryan ` RidallDirector, Executive Officer
- Offering amount
- $11.3M
- Amount sold
- $11.3M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$37.9MraisedMar 2021 · 50 investors · BiotechnologyRule 506(b)
▶$37.9MraisedMar 2021 · 50 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vincent MiletoExecutive Officer, Director
- Bryan RidallDirector, Executive Officer
- Mark RidallExecutive Officer, Director
- Robert M. PollaroExecutive Officer, Director
- Offering amount
- $37.9M
- Amount sold
- $37.9M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
DoximityDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
PractoPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
Companies working in the same space as Orcosa.
Frequently asked questions
- What does Orcosa do?
- Orcosa is a clinical-stage life-sciences company developing the Rapid Infusion Technology (RITe) platform, orally disintegrating tablets designed to improve drug absorption through the cheek tissue without water. The company controls formulation, development, and manufacturing in-house and is advancing a proprietary cannabinoid composition for the management of pain and inflammation.
- Who founded Orcosa?
- Orcosa was founded by Vincent T. Mileto in 2020.
- How much funding has Orcosa raised?
- Orcosa has disclosed $56.5M raised across 3 rounds.
- Where is Orcosa headquartered?
- Orcosa is headquartered in Ewing, US.